One of the main treatment challenges in alcohol use disorder (AUD) is the high rate of craving in combination with decreased cognitive functioning including impaired decision making and impulse ...

February 28, 2011 — The US Food and Drug Administration (FDA) has approved guanfacine extended-release tablets (Intuniv, Shire Plc) as adjunctive therapy to stimulants such as methylphenidate in the ...

September 3, 2009 — The US Food and Drug Administration has approved guanfacine extended-release tablets (Intuniv; Shire plc) for the once-daily treatment of attention-deficit hyperactivity disorder ...

Norepinephrine plays a significant role in the working memory functions of the prefrontal cortex by its actions at alpha-2a noradrenergic receptors. Guanfacine has demonstrated efficacy in reversing ...

Please provide your email address to receive an email when new articles are posted on . Extended-release guanfacine was safe and effective for short-term treatment of hyperactivity, impulsiveness and ...

Learn everything you need to know about Guanfacine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Review the side-effects of Guanfacine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents First once-daily nonstimulant to be ...

Apotex recalled three lots of Guanfacine, a drug used to treat ADHD, after finding one lot had trace amounts of a drug used to treat schizophrenia, bipolar disorder and depression. That medication is ...

Scientists say they may have uncovered a new treatment for one of the most common symptoms of Long Covid. Researchers at Yale University managed to lift the “brain fog” of eight patients with the ...